Merck KGaA

Type: Company

Name: Merck KGaA

Nationality: Germany

Web Address: http://www.merck.de/

Fact Sheet: Fact Sheet for Merck KGaA

First reported 4 hours ago - Updated 20 mins ago - 5 reports

Ranbaxy Laboratories Ltd

European regulator fines Ranbaxy and 8 others for blocking generic drugs

The European antitrust regulator today fined nine pharmaceutical companies including Ranbaxy a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant drug to the market.The European Commission (EC) has fined Germany's ... [Published domain-b - 32 mins ago]

Entities: Ranbaxy Laboratories Ltd, Citalopram, Merck KGaA, Generics UK, Alpharma Inc

First reported 5 hours ago - Updated 1 hour ago - 4 reports

European Commission

EU Commission Fines Danish Drugmaker Lundbeck And 8 Other Pharma Companies Over Pay-For-Delay Deal

The European Commission Wednesday fined several drug makers for a total of 146 million euros ($196 million) for delaying the supply of a cheaper version of Danish pharma giant Lundbeck's (CPH: LUN) anti-depressant drug, Citalopram, to the market.More ... [Published International Business Times Canada - 1 hour ago]

Entities: European Commission, Generic Drug, Drugs, Citalopram, Merck KGaA

First reported 3 hours ago - Updated 1 hour ago - 2 reports

H Lundbeck AS

Lundbeck Fined $125.6 Million in EU Probe of Generic Delays

(Updates with Lundbeck appeal in fifth paragraph.)June 19 (Bloomberg) -- H. Lundbeck A/S, the Nordic region’s second-largest drugmaker, was fined 93.8 million euros ($125.6 million) by the European Union in its first case over pay-for- delay deals that ... [Published Washington Post - 1 hour ago]

Entities: H Lundbeck AS, European Union, Antitrust, Merck KGaA

First reported Jun 14 2013 - Updated Jun 14 2013 - 2 reports

Threshold Pharmaceuticals Inc

Threshold Pharmaceuticals, Inc. (THLD): A Biotech That Investors Need To Know About

Biotech stocks can provide astronomical returns but also depressing losses. Before investing in these volatile stocks, investors need to understand the full picture, including fundamentals, technical, and upcoming catalysts. Below are 2 biotechs that ... [Published InsiderMonkey.com - Jun 14 2013]

Entities: Threshold Pharmaceuticals Inc, Celgene Corporation, Biotechnology, Abraxane

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Merck KGaA

Technical Support Specialist

EMD Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human ... [Published Molecular Systems Biology - Jun 13 2013]

Entities: Life Science, EMD Millipore, Merck KGaA

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

Latin American cancer vax races Big Pharma rivals

The lung cancer vaccine race has brought together an unusual mix of players. Merck KGaA was in a good position, but its vaccine disappointed in Phase III, while GlaxoSmithKline ($GSK) could report data on its candidate this year. Then there is the Cuba-Argentina ... [Published FierceVaccines - Jun 12 2013]

Entities: cancer vaccine, Vaccine, Big Pharma

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

EMD Millipore Direct Detect and Muse Products Tapped as Finalists in American Business Awards

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, was named a finalist in the New Product of the Year category of the 2013 American Business Awards for two products introduced this past year: the Muse Cell Analyzer and the ... [Published Individual.com - Jun 12 2013]

Entities: EMD Millipore, American Business Corp, Merck KGaA, Protein, Life Science

First reported Jun 03 2013 - Updated Jun 04 2013 - 19 reports

Nine pharma firms face EU fines over pay-for-delay deals

Lundbeck could be the hardest hit with a maximum penalty of 240m eurosNine pharmaceutical companies are facing fines over deals to prevent the arrival of generic competition, with Danish firm Lundbeck said to be facing a 'sizeable' financial penalty.Lundbeck, ... [Published PMLive - Jun 04 2013]

Entities: European Union, Antitrust Law, European Commission, H Lundbeck AS

First reported May 28 2013 - Updated May 29 2013 - 3 reports

Merck KGaA Upgraded to “Buy” at Jefferies Group (MRK)

Merck KGaA (FRA: MRK) was upgraded by equities researchers at Jefferies Group from a “hold” rating to a “buy” rating in a research report issued on Tuesday, AnalystRatings.Net reports. The firm currently has a €54.00 ($70.13) target price on the stock, ... [Published Mideast Time - May 29 2013]

Entities: Merck KGaA, Jefferies Group Inc, Stocks, Morgan Stanley & Co, Overweight

First reported May 23 2013 - Updated May 23 2013 - 2 reports

Merck KGaA Now Covered by Analysts at Morgan Stanley (MRK)

Morgan Stanley started coverage on shares of Merck KGaA (FRA: MRK) in a research note issued on Thursday, Stock Ratings Network reports. The firm set an “overweight” rating and a €142.00 ($184.42) price target on the stock.Several other analysts have ... [Published The Utah People's Post - May 23 2013]

Entities: Merck KGaA, Morgan Stanley & Co, Stocks

First reported May 22 2013 - Updated May 23 2013 - 5 reports

Campus Biotech buys Merck Geneva headquarters

The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus. ... [Published PBR - News - May 23 2013]

Entities: Merck KGaA, Biotechnology, Geneva

First reported May 22 2013 - Updated May 22 2013 - 3 reports

Data on Merck KGaA's L-BLP25 - Analyst Blog

ETF SPY nflx ETFPY ETFC efii et eeb dia AXP GOOG DVR EAT dgp DIS AAPL DELL dsdfs DKK DRI ... [Published Zecco - May 22 2013]

Entities: Merck KGaA, Apple Inc, Google Inc

Quotes

Almunia said: "It is unacceptable that a company pays off its competitors to stay out of its market and delay the entry of cheaper medicines. Agreements of this type directly harm patients and national health systems, which are already under tight budgetary constraints. The Commission will not tolerate such anti-competitive practices"

Almunia fines Lundbeck and rivals for fudging competition on medicines [Published European Voice - 20 mins ago]

Dr. Timm Jessen, CEO of Bionamics GmbH and founder of NEU², about the further expansion of the NEU² consortium: "With Lophius Biosciences we could attract an attractive new partner for the consortium. Its expertise in the diagnostic area will complement our expertises within NEU², also to the benefit of our current consortium members."

Lophius Biosciences GmbH Joins NEU² and Receives Substantial Grant Funding for the Diagnosis and ... [Published FierceBiotech - 57 mins ago]

"The agreements gave Lundbeck the certainty that the generics producers would stay out of the market for the duration of the agreements without giving the generic producers any guarantee of market entry thereafter" the EC statement said

European Commission fines Ranbaxy and 8 other pharma firms [Published zeenews.com - 1 hour ago]

"This is the first case of likely many for which we will see fines imposed" he wrote in a note

Ranbaxy filed Rs 81 crore by EU for delaying generics [Published NDTV Profit - 1 hour ago]

More Content

sort by: Date \| Relevance
Almunia fines Lundbeck and rivals for fudging c... [Published European Voice - 20 mins ago]
European regulator fines Ranbaxy and 8 others f... [Published domain-b - 32 mins ago]
Lophius Biosciences GmbH Joins NEU² and Receive... [Published FierceBiotech - 57 mins ago]
European Commission fines Ranbaxy and 8 other p... [Published zeenews.com - 1 hour ago]
EU Commission Fines Danish Drugmaker Lundbeck A... [Published International Business Times Canada - 1 hour ago]
Lundbeck Fined $125.6 Million in EU Probe of Ge... [Published Washington Post - 1 hour ago]
Ranbaxy filed Rs 81 crore by EU for delaying ge... [Published NDTV Profit - 1 hour ago]
Now Available: Merck KGaA (MRK) - Financial and... [Published Live-PR.com - 2 hours ago]
Commission fines pharma company Lundbeck [Published New Europe - 2 hours ago]
EU fines Lundbeck and others 146 mln euros for ... [Published Sharenet - 2 hours ago]
Antitrust: Commission fines Lundbeck and other ... [Published European Commission - 3 hours ago]
Midday Express of 2013-06-19 [Published European Commission - 3 hours ago]
EUROPEAN COMMISSION: Midday Express of 2013-06-19 [Published 4 Traders - 3 hours ago]
Lundbeck Fined $125.6 Million in EU Probe of Ge... [Published Washington Post - 3 hours ago]
Ranbaxy among 9 cos fined by European Commissio... [Published Hindu Business Line - 3 hours ago]
EU fines Denmark's Lundbeck 94 mn euros in gene... [Published EU Business - 4 hours ago]
UPDATE 1-EU fines Lundbeck, 8 others 146 mln eu... [Published CNBC - 4 hours ago]
Lundbeck Fined $125.6 Million by EU Drug Delay ... [Published Bloomberg - 4 hours ago]
EU Fines Lundbeck EUR93.9 Million for Delaying ... [Published 4 Traders - 4 hours ago]
EU fines Lundbeck, 8 others 146 mln euros for b... [Published Reuters UK - 5 hours ago]
Supreme Court slaps pharma aside in pay-for-del... [Published FiercePharma - Jun 17 2013]
Threshold Pharmaceuticals, Inc. (THLD): A Biote... [Published InsiderMonkey.com - Jun 14 2013]
Threshold Pharmaceuticals: A Biotech That Inves... [Published Motley Fool - Jun 14 2013]
Luminex Increasing Diagnostic Equipment Market ... [Published Individual.com - Jun 14 2013]
Industry Looks to New Blow-Fill-Seal Uses [Published Pharmaceutical & Medical Packaging News - Jun 13 2013]
Technical Support Specialist [Published Molecular Systems Biology - Jun 13 2013]
Cancer Diagnostics Partnering Terms and Agreements [Published Individual.com - Jun 13 2013]
EMD Millipore Launches PluriSTEM Human ESiPS Me... [Published Big News Network - Jun 12 2013]
Research and Markets: Musculoskeletal Partnerin... [Published Yahoo! Finance - Jun 12 2013]
Latin American cancer vax races Big Pharma rivals [Published FierceVaccines - Jun 12 2013]

Blogs

sort by: Date \| Relevance
Momenta Spars with Amphastar; Says Federal Circ... [Published FDA Law Blog - Jun 05 2013] By Kurt R. Karst –Earlier this week, Momenta Pharmaceuticals, Inc. and Sandoz Inc. (“Petitioners”) filed their reply to the brief filed late last month by Amphastar Pharmaceuticals, Inc. (“Amphastar”) opposing Petitioners’ petition the U.S. Supreme Court ...
Nine pharma firms face EU fines over pay-for-de... [Published PharmaGossip - Jun 04 2013] Nine pharmaceutical companies are facing fines over deals to prevent the arrival of generic competition, with Danish firm Lundbeck said to be facing a 'sizeable' financial penalty. Lundbeck, Merck KGaA, Generics UK, Arrow, Resolution Chemicals, ...
Campus Biotech buys Merck Geneva headquarters [Published PBR - News - May 23 2013] The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus. ...
Johnson & Johnson and Merck Lead the Dow Health... [Published Wall St. Cheat Sheet - May 19 2013] Johnson & Johnson ( NYSE:JNJ ): Current price $88.06 The J&J company Biosense Webster is announcing results from the SMART-AF IDE study on the safety and effectiveness of the Thermocool Smarttouch catheter 85.85 +0.09. the firm reported the 12-month ...
Deals Of The Week Is Keeping Score – Valeant Wa... [Published The IN VIVO Blog - May 17 2013] Whether the pastime is baseball, Broadway or the daytime soaps, the old adage is that you can’t keep track of the players without a scorecard. The M&A front involving specialty pharma and generic drug makers has become similarly frenzied, as Canada’s ...

Press Releases

sort by: Date \| Relevance
DGAP-PVR: Merck KGaA: Release according to Arti... [Published GlobeNewswire: Advertising News - Jun 12 2013]
TransCelerate BioPharma Inc. Reveals Collaborat... [Published PR Newswire - Jun 03 2013]
Symphogen Reports New Data on Anti-EGFR Monoclo... [Published Business Wire Health News - Jun 02 2013]
Symphogen to Report New Data on Anti-EGFR Monoc... [Published Business Wire Health News - May 30 2013]
Luminex Corporation and EMD Millipore Extend Th... [Published PR Newswire: General Business - May 28 2013]